Rebiotix Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rebiotix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013521
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases healthy, live and human-derived microbes into the intestinal tract of a patient to treat diseases. The company’s lead product, RBX2660 is a non-antibiotic therapy that is used to treat clostridium difficile infection. It also develops therapies for ulcerative colitis, hepatic encephalopathy and multi-drug resistant organisms. Rebiotix is headquartered in Roseville, Minnesota, the US.

Rebiotix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rebiotix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rebiotix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Rebiotix Raises 8.5 Million in Venture Financing 10
Rebiotix Raises USD25 Million in Series B Financing 11
MikrobEX Secures US$2.8 Million In Venture Financing 12
Rebiotix Inc – Key Competitors 13
Rebiotix Inc – Key Employees 14
Rebiotix Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jun 20, 2017: Rebiotix Continues Management Team Expansion with Appointment of Greg Fluet as Chief Business Officer 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Rebiotix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rebiotix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rebiotix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Rebiotix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rebiotix Raises 8.5 Million in Venture Financing 10
Rebiotix Raises USD25 Million in Series B Financing 11
MikrobEX Secures US$2.8 Million In Venture Financing 12
Rebiotix Inc, Key Competitors 13
Rebiotix Inc, Key Employees 14

★海外企業調査レポート[Rebiotix Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gamma Medica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gamma Medica Inc (Gamma Medica), formerly Gamma Medica Ideas Inc is a medical device company that offers imaging solutions. The company designs, develops and manufactures imaging systems for clinical and pre-clinical applications. It offers lumagem, lumagem mbi workflow, lumagem procedure ov …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bilfinger Tebodin BV:企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Teijin Ltd (3401):製薬・医療:M&Aディール及び事業提携情報
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • eBay Inc:戦略・SWOT・企業財務分析
    eBay Inc - Strategy, SWOT and Corporate Finance Report Summary eBay Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • LifeScan Inc:企業の製品パイプライン分析
    Summary LifeScan Inc (LifeScan), a subsidiary of Platinum Equity LLC, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managemen …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • nib Holdings Limited:企業の戦略・SWOT・財務情報
    nib Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DTE Energy Co (DTE):石油・ガス:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • OPTIMA packaging group GmbH:戦略・SWOT・企業財務分析
    OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report Summary OPTIMA packaging group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Performance Food Group:企業の戦略・SWOT・財務分析
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tauron Polska Energia SA:発電所・企業SWOT分析
    Tauron Polska Energia SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • Albert David Ltd (524075):企業の財務・戦略的SWOT分析
    Summary Albert David Ltd (ADL), a subsidiary of Kothari Group is a manufacturer and distributor of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles. The company’s products include sodium stibogluconate and placentrex. It offers pro …
  • Wolverine World Wide, Inc. (WWW):企業の財務・戦略的SWOT分析
    Wolverine World Wide, Inc. (WWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務情報
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆